EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Precision medicine to identify, prevent, and treat pediatric obesity

Emma M Tillman iD, Selsbiel Mertami

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · 2024

DOI: 10.1002/phar.4626 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2024. Verfasst von Emma M Tillman und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Pharmacology, Indiana University School of Medicine (IUSM), Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Anti-Obesity Agents, Pediatric Obesity, Pharmacogenetics, Precision Medicine. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, Indiana University Simon Cancer Center Educational Pathways for Cancer Research Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pediatric obesity is a growing health concern that has many secondary adverse health implications. Personalized medicine is a tool that can be used to optimize diagnosis and treatments of many diseases. In this review, we will focus on three areas related to the genetics of pediatric obesity: (i) genetic causes predisposing to pediatric obesity, (ii) pharmacogenomics that may predict weight gain associated with pharmacotherapy, and (iii) pharmacogenomics of anti‐obesity pharmacotherapy. This narrative review evaluates genetic cause of pediatric obesity and how genetic findings can be used to optimize pharmacotherapy to minimize weight gain and optimize obesity treatment in pediatric patients. Pediatric obesity has many genetic causes including genomic obesity syndromes and monogenic obesity disorders. Several genetic etiologies of obesity have current or emerging targeted genetic therapies. Pharmacogenomic (PGx) targets associated with pharmacotherapy‐induced weight gain have been identified for antipsychotic, antiepileptic, antidepressant therapies, and steroids, yet to date no clinical guidelines exist for application use of PGx to tailor pharmacotherapy to avoid weight gain. As legislation evolves for genetic testing coverage and technology advances, this will decrease cost and expand access to genetic testing. This will result in identification of potential genetic causes of obesity and genes that predispose to pharmacotherapy‐induced weight gain. Advances in precision medicine can ultimately lead to development of clinical practice guidelines on how to apply genetic findings to optimize pharmacotherapy to treat genetic targets of obesity and avoid weight gain as an adverse event associated with pharmacotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Obesity AgentsPediatric ObesityPharmacogeneticsPrecision MedicineChildHumansGenetic TestingWeight Gain

Stichwörter der Autor:innen

genomicsobesitypediatricpharmacogeneticprecision medicine

Substanzen

Anti-Obesity Agents

Autor:innen und Institutionen

  • Division of Clinical Pharmacology, Indiana University School of Medicine (IUSM), Indianapolis, Indiana, USA.

ORCID-Profile: Emma M Tillman

Förderung

  • NCI NIH HHS
  • Indiana University Simon Cancer Center Educational Pathways for Cancer Research Award

Zitieren

APA

Tillman, E. M., & Mertami, S. (2024). Precision medicine to identify, prevent, and treat pediatric obesity. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1002/phar.4626

Vancouver

Tillman EM, Mertami S. Precision medicine to identify, prevent, and treat pediatric obesity. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2024. doi:10.1002/phar.4626

BibTeX
@article{Tillman2024,
  author = {Tillman, Emma M and Mertami, Selsbiel},
  title = {Precision medicine to identify, prevent, and treat pediatric obesity},
  journal = {Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
  year = {2024},
  doi = {10.1002/phar.4626}
}
Kostenlos starten →